Pacira Pharmaceuticals, Inc.(PCRX) recently announced positive data from a phase IV study, EXCLAIM, evaluating the use of Exparel for postsurgical analgesia in patients undergoing four common plastic surgery procedures, namely, abdominoplasty, breast augmentation, breast reduction or a combination of abdominoplasty/breast procedure. The study revealed low pain scores, high satisfaction with pain control, minimal opioid use [...]
Optibase Ltd. (NASDAQ: OBAS) today announced financial results for the third quarter ended September 30, 2010.
Revenues from fixed income real estate totaled $400,000 for the quarter ended September 30, 2010, compared with $408,000 for the previous quarter. Net income for the quarter ended September 30, 2010 was $5.9 million or $0.37 per basic and diluted share, compared with a net income of $206,000 or $0.02 per basic and diluted share for the second quarter of 2010.
For the period of...
Optibase Narrows Loss; Manulife Profits Jump 10% Profits; Biggest Takeover Ever Down Under; ING Sidesteps Subprime Pains - Maybe
Optibase Ltd. (OBAS), an advanced digital-video solutions based in Israel, announced that third-quarter revenue soared 21% to $5.2 million - up from [...]